Lilly in Advanced Talks to Acquire Kelonia for Over $2 Billion—Is a 39x P/E Still Too Rich? Life Science
No Longer Afraid of Injections, Eli Lilly’s Oral Weight Loss Drug Foundayo Targets a Multibillion-Dollar Market Life Science
OpenAI Launches Life Science AI Model GPT-Rosalind, Entering Drug Discovery Arena Life Science, Technology
Overall Weakness in the Healthcare Sector, Why These Two Stocks Are Worth Long-Term Positioning Life Science
Intuitive Surgical Sits at the Center of a Demographic Tailwind That Won’t Fade Soon Life Science, Technology
Why Institutions Are Turning Bullish on Biohaven—and the Catalyst That Could Unlock Its Value Life Science
The Most Hated Trade on Wall Street Is Quietly Setting Up for a Massive Rotation Financial Service, Life Science
A Melanoma Drug Successfully Launched, Yet Iovance’s Stock Has Underperformed the Market for Three Years Life Science
